Thursday, June 27, 2019

Hilleman Labs licenses oral cholera vaccine to Bharat Biotech for development and commercialisation

Hilleman Labs licenses oral cholera vaccine to Bharat Biotech for development and commercialisation Krishna Ella, Chairman Managing Director of Bharat Biotech, said the company has a capacity to deliver 50 million doses per year.

from Moneycontrol Business News https://ift.tt/2LjhVRH

No comments:

Post a Comment

Sudarshan Chemical Industries acquires Germany-based world’s second biggest pigment company Heubach Group

Sudarshan Chemical Industries announced the acquisition of Heubach Group for Rs 1,180 crore. Shares surged 20% on the news. Heubach Group is...